SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437786-16-000047
Filing Date
2016-05-10
Accepted
2016-05-10 16:42:54
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imdz331201610-q.htm 10-Q 821484
2 EXHIBIT 10.1 amendedrsuagreement.htm EX-10.1 46215
3 EXHIBIT 31.1 ex311imdz2016q1.htm EX-31.1 7997
4 EXHIBIT 31.2 ex312imdz2016q1.htm EX-31.2 8097
5 EXHIBIT 32.1 ex321imdz2016q1.htm EX-32.1 4852
6 EXHIBIT 32.2 ex322imdz2016q1.htm EX-32.2 5102
  Complete submission text file 0001437786-16-000047.txt   3820511

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imdz-20160331.xml EX-101.INS 610446
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20160331.xsd EX-101.SCH 31145
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20160331_cal.xml EX-101.CAL 46905
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20160331_def.xml EX-101.DEF 148210
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20160331_lab.xml EX-101.LAB 457424
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20160331_pre.xml EX-101.PRE 258420
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 161636373
SIC: 2834 Pharmaceutical Preparations